Analyses / Public Summary / 119 · HR 6361 Public Summary

119-HR-6361 Journalist Public Summary

119 · HR 6361 Ban AI Denials in Medicare Act

Stops HHS from testing the WISeR prior-authorization model and bars any future Medicare Innovation Center pilots that add prior authorization (including AI tools) to traditional Medicare; introduced December 2, 2025 and currently in House committees.

Published
03 Dec 2025
Updated
03 Dec 2025
Tags
public-summary · US-Congress · Medicare
Unvetted
01 · Section

Headline Summary

A straightforward ban on adding prior authorization—whether manual or AI-driven—to traditional Medicare test programs, and an immediate stop to the planned WISeR pilot.

02 · Section

What It Does

The bill blocks the Department of Health and Human Services (HHS) from launching the WISeR model, a pilot that would have required advance approval for certain services, and amends current law so the Medicare Innovation Center (CMMI) cannot test any model that introduces prior authorization in traditional Medicare Parts A or B—including through artificial intelligence. In plain terms: Medicare’s fee-for-service program could not run trials that make patients or providers get pre-approval before care is covered.

03 · Section

Why It Matters

  • For patients: Prior authorization can delay or deny care; supporters say banning it in Medicare pilots prevents algorithm‑driven or bureaucratic hurdles for seniors.
  • For clinicians: Could reduce paperwork and uncertainty tied to experimental payment rules.
  • For taxpayers and policymakers: Limits a cost‑control tool that some believe reduces unnecessary services, potentially affecting efforts to test ways to curb waste in Medicare.
04 · Section

Who’s For It

  • Lead sponsors: Rep. Greg Landsman (D‑OH) and Rep. Bonnie Watson Coleman (D‑NJ).
  • Supporters’ arguments: Protect seniors from delays or denials tied to prior authorization; prevent AI or automated systems from overriding clinical judgment; keep traditional Medicare simple while other reforms are studied.
05 · Section

Who’s Against It

  • Likely opponents: Lawmakers who favor CMMI experimentation and stricter utilization controls; stakeholders focused on reducing overtreatment and costs.
  • Critics’ arguments: Prior authorization—human or AI‑assisted—can target waste and inappropriate care; banning it in pilots ties policymakers’ hands and may slow learning about how to manage Medicare spending.
06 · Section

What’s Next

Status as of December 2, 2025: Introduced in the House and referred to the Committees on Ways and Means and Energy and Commerce. Next steps would typically include committee hearings/markup, a House floor vote, consideration in the Senate, and then the President’s decision.

Discussion